Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by TheRock07on Jun 03, 2016 5:30pm
104 Views
Post# 24933154

RE:Support ???

RE:Support ???There is none.

Why would you expect any?

This is a poorly executed Valeant roll up strategy .
With debt of $175 million and  inadequate free cash flows, the expectation of capital gains here is wishful thinking.

I doubt very much if this wretch was broken up for sale that the proceeds would pay off the debt.

Avoid..
<< Previous
Bullboard Posts
Next >>